Vor Biopharma Inc. (VOR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.39
0.05 (3.73%)
At close: Jan 15, 2025, 2:34 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -1.28 | -2.9 | -6.28 | -32.13 | -121.6 | -51.12 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.00 | 1.05 | 2.00 | 28.84 | 182.20 | -31.37 |
P/FCF Ratio | -1.49 | -2.81 | -5.91 | -34.42 | -131.28 | -79.77 |
P/OCF Ratio | -1.51 | -3.09 | -6.25 | -38.36 | -141.25 | -79.77 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.24 | 0.16 | 0.08 | 0.38 | n/a | -0.66 |
Quick Ratio | 9.04 | 18.06 | 21.12 | 4.81 | 3.45 | 0.12 |
Current Ratio | 9.04 | 18.06 | 21.12 | 4.81 | 3.45 | 0.12 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | -17.13 | -2.85 |
Return on Equity (ROE) | -0.78 | -0.36 | -0.32 | -0.9 | -1.5 | 0.61 |
Return on Assets (ROA) | -0.59 | -0.3 | -0.28 | -0.57 | -1.16 | -4.12 |
Return on Capital (ROIC) | -0.69 | -0.33 | -0.3 | -0.66 | -1.36 | 0.42 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |